Yan et al. further demonstrated that elevated HDAC expression in gynecological cancers reduces NK and CD8 + T cell infiltration and immune-activating gene expression, an effect counteracted by HDAC inhibitors to boost anti-tumor immunity [16]. The gene discussed is HDAC9; the disease is female reproductive organ cancer.